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Background and Objectives
Traditionally eosinophils have been considered terminally differentiated cells that play
a role in host protection against parasites. However, there is some evidence showing
that eosinophils are, in fact, multifunctional leukocytes involved in inflammatory
responses, as well as in tissue homeostasis. We characterized the transcriptome pro-
file of human eosinophils, and, for the purpose of comparison, the transcriptome pro-
file of neutrophils, monocytes and hematopoietic progenitor cells. Moreover, we stud-
ied the activation of selected cellular processes for which a significant differential
expression was demonstrated.
Design and Methods
We profiled gene expression using Affymetrix GeneChips. DNA repair capacity was
tested using the comet assay. Nucleoli and their activity were characterized by trans-
mission electron microscopy analysis, silver staining of nucleolus regions (AgNOR)
and RNA staining.
Results
Gene expression profiling showed that eosinophils appear hierarchically closer to
monocytes than to neutrophils. Gene ontology mapping of differentially expressed
genes revealed that eosinophils express categories very similar to those expressed
by monocytes, related to DNA repair and nucleolar functions. Moreover, our data show
that eosinophils and monocytes maintain the ability to repair both double and single
strand DNA breaks, whereas neutrophils lack this capacity. Furthermore, eosinophils
exibit nucleolar activity, which is lacking in neutrophils, but resembles that in mono-
cytes.
Interpretation and Conclusions
The presence of large, active nucleoli in eosinophils, coupled to marked activity of
DNA repair systems, suggests that eosinophils are not terminally differentiated cells.
Indeed, their transcriptome profile and functional properties are more similar to those
of non-terminally differentiated cells such as monocytes, rather than to neutrophils. 
Key words: eosinophils, gene expression profile, DNA repair, nucleolar function,
myeloid differentiation.
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ABSTRACT
ORIGINAL ARTICLES
Eosinophils are now known to be multifunctionalleukocytes involved in the pathogenesis of numer-ous inflammatory processes, including parasitic
helminth infections and allergic diseases.1 In response to
diverse stimuli, eosinophils are recruited from the circula-
tion into inflammatory foci, where they modulate
immune responses through an array of mechanisms.
Eosinophils can release numerous cytokines, chemokines
and lipid mediators.2,3 These molecules have pro-inflam-
matory effects, including upregulation of adhesion sys-
tems, modulation of cellular trafficking, regulation of vas-
cular permeability, mucus secretion and smooth muscle
contraction. Eosinophils can trigger antigen-specific
immune responses by acting as antigen-presenting cells.
Furthermore eosinophils can serve as major effector cells
inducing tissue damage and dysfunction by releasing
toxic granule proteins and lipid mediators.2,3 In recent
years, eosinophils have been shown to be involved in
numerous other biological processes, including post-
pubertal mammary gland development,4 estrus cycling,4,5
reactions to organ transplantation,6 allergic inflammatory
responses7 and neoplasia.8
Some investigators have shown that eosinophils are
implicated in airway epithelium remodeling.9 Eosinophils
are capable of producing a wide range of cytokines
involved in tissue remodeling such as transforming growth
factor (TGF)-α, TGF-β1 and vascular endothelial growth
factor (VEGF), and evidence from animal models supports
the key role of eosinophils in this process: in fact, deletion
of the interleukin-5 gene10 has been shown to suppress
lung eosinophilia and airway remodeling in murine mod-
els of allergic asthma.11 In inflammatory conditions,  includ-
ing asthma and inflammatory bowel disease, localization
of eosinophils to nerves is associated with plasticity,
specifically nerve cell remodeling.12 Eosinophil adhesion to
nerve cells, via nerve cell intercellular adhesion molecule-1,
results in an adhesion-dependent release of granule pro-
teins including the major basic proteins (MBP) and
eosinophil-derived neurotoxin. These granule proteins
released from eosinophils may affect nerve cell signaling
and survival, leading to nerve cell remodeling. In particular,
MBP1 may regulate peripheral nerve plasticity through the
inhibition of apoptosis.
Although, as a whole, eosinophils have historically been
considered end-stage cells involved in host protection
against parasites, numerous lines of evidence have now
changed this perspective by showing that eosinophils are
pleiotropic multifunctional leukocytes involved in the ini-
tiation and propagation of diverse inflammatory respons-
es, as well as modulators of adaptive immunity and tissue
remodeling. Over the past 10 years, global gene expression
profiling has changed the way of investigating the biology
of tissue cells. The capacity of microarray information has
increased consistently, so that expression of the entire tran-
scriptome can now be measured. These data, along with
functional annotations of the genome, provide researchers
with global information about the transcriptional activa-
tion or down-regulation of specific functional modules.
Very few studies have been published so far about the
gene expression profile of eosinophils, and all studies that
have been published are focused on the molecular mecha-
nisms underlying the eosinophils’ involvement in atopic or
inflammatory diseases.3 No data are available about the
molecular phenotype of circulating eosinophils, nor about
the specific differences between the gene expression pro-
file of eosinophils and the transcriptome profiles of mature
leukocytes. To gain new insights into the molecular and
functional properties of eosinophils, we investigated the
molecular phenotype of human eosinophils and compared
it with that of neutrophils, monocytes and CD34+
hematopoietic progenitor cells.
Design and Methods
Cell populations
To obtain peripheral blood CD34+ hematopoietic pro-
genitor cells, 12 healthy donors were given glycosylat-
ed recombinant human granulocyte colony-stimulating
factor (rh G-CSF) (lenograstim, Rhone-Poulenc Rorer,
Milan, Italy) administered subcutaneously at a dose of
10 µg/kg/day for 5-6 days. Progenitor cell purification
and phenotypic analysis were performed as previously
described.12 Monocytes (CD14+ cells), neutrophils
(CD16+) and eosinophils (CD16–) were isolated from
the peripheral blood of 12 healthy donors using mag-
netic cell-sorting procedures. Briefly, the peripheral
blood was subjected to centrifugation on a Ficoll-Hy-
paque gradient; CD14+ cells were purified from periph-
eral blood mononuclear cells utilizing a CD14 Micro-
Beads kit (Miltenyi Biotech, Auburn, CA, USA).
Simultaneously, CD16+ and CD16– cells were isolated
by positive selection or depletion, respectively, from
the pellet using CD16 MicroBeads (Miltenyi Biotech,
Auburn, CA, USA).
Aliquots of purified Lin+CD34+, CD14+, CD16+ and
CD16– cells were reanalyzed on a Coulter Epics XL flow
cytometer to assess their purities which were
98.2±0.4%, 97.2±0.5%, 98.5±0.7% and 99.0±0.6%,
respectively. For differentiated myeloid cells, flow cyto-
metric data were confirmed by morphological analysis
(Online Supplementary Figure 1). 
RNA extraction and microarray data analysis
Total RNA was isolated from each cell population
(2×105 cells) from each donor using a modification of the
guanidinium isothiocyanate procedure and ultracen-
trifugation on a cesium chloride gradient.12 RNA sam-
ples originating from 12 donors were pooled in order to
obtain at least 2 µg per sample. 
The biotin-labeled target synthesis reactions as well
as the Affymetrix HG-U95Av2 GeneChip (Affymetrix,
Santa Clara, CA, USA) arrays’ hybridization, staining
and scanning were performed as previously described.12
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Differentially expressed genes were selected, as the
sequences showing a change call I or D, using the
GeneChip Operating Software (GCOS) comparison
analysis algorithm in 100% of the pair-wise compar-
isons between each differentiated myeloid cell popula-
tion and the other samples and a signal log ratio of at
least one (2-fold change) (Supplementary Table 3). The
generated list and, independently, the GCOS generated
absolute analysis data were uploaded onto Gene-
SpringTM software version 7.2 (Silicon Genetics,
Redwood City, CA, USA) in order to perform clustering
analysis. To identify the gene ontology (GO) categories
characterized by significant numbers of genes differen-
tially expressed in each cell population we utilized an
accessory program of GenMAPP 2.0 software,
MAPPFinder 2.0β.13
DNA repair functional assay (comet assay)
Alkaline and neutral single-cell gel electrophoresis
(comet assay) was performed to detect single- and dou-
ble-strand DNA breaks, respectively. The comet assay
was carried out using the Trevigen comet assay kit
(Trevigen Inc., Gaithersburg, Maryland, USA), accord-
ing to the manufacturer’s instructions. CD34+ cells,
monocytes and granulocytes were treated for 2 hours
at 37°C with 200 µM methyl methanesulfonate (MMS)
to induce single-strand DNA breaks or with 0.2 µM
mitoxantrone to induce double-strand breaks, then
washed twice with ice-cold phosphate-buffered saline,
and finally rinsed with RPMI/10% fetal bovine serum.
Alkaline and neutral comet assays were performed
immediately after these treatments and 6 hours after
the removal of the MMS or mitoxantrone. Samples
were stained with the supplied SYBR green dye, and
the slides were viewed using a Zeiss Axioskop 40 epi-
fluorescence microscope. To ensure random sampling,
50 images/slide were captured and the comet moment
in each cell was quantified using Scion Image software
(Scion Corporation) to outline each comet head and tail
manually, then integrating the SYBR fluorescence with-
in the outline. The comet moment was calculated using
the following equation described by Kent et al.:14 comet
moment= Σ0-n [(intensity of DNA at distance X) × (dis-
tance)]/intensity of total DNA. The mean comet-
moment value obtained from control samples was sub-
tracted from the mean comet-moment value for each
drug treatment. Data shown are the mean values from
five independent experiments performed on samples
from five different donors. The percentage of remain-
ing MMS- or mitoxantrone-induced damage was calcu-
lated by comparison with the total score (100%) of ini-
tial DNA damage induced by MMS or mitoxantrone
treatment 15
Transmission electron microscopy (TEM) analysis
Cells were centrifuged at 12000 × g for 5 min at 10°C
and routinely processed for ultrastructural analyses.16
Morphometric analysis of CD16+, CD16–, CD14+ and
CD34+ cells was performed on at least 50 micrographs
for each cell type.16
Staining for nucleolar RNA and nucleolus organizer
regions (NOR)
Nucleoli were investigated in cytospins of CD34+
stem/progenitor cells, monocytes, neutrophils and
eosinophils purified from the peripheral blood of five
healthy donors. Nucleoli were visualized by cytochem-
ical procedures for the demonstration of RNA and silver
stained proteins of NOR. In order to detect RNA-con-
taining structures, cytospins were stained with buffered
methylene blue without prior fixation.17,18
Silver staining was performed to detect active NOR
according to a previously described procedure.19
Results
The mRNA expression of phenotype-specific markers
reveals the high purity of the sorted populations
We assessed gene expression in all cell populations using
the Affymetrix HG-U95Av2 GeneChip array, representa-
tive of 12625 transcripts. All the data have been deposited
in the MIAME compliant Gene Expression Omnibus
(GEO) public database, at http://www.ncbi.nlm.nih.gov/geo.
The GEO accession numbers are reported in Supplemental
Table 2.
In order to evaluate the purity of sorted cell populations
more stringently, we initially looked for expression of a
large number of genes, e.g. surface markers, immune
defense proteins and transcription factors that are associat-
ed with neutrophils, monocytes and eosinophils.
Supplemental Table 2 shows the results of this analysis
revealing that each cell population preferentially expresses
the transcripts related to the respective phenotype; in fact,
the data are consistent with results already published in lit-
erature (Supplemental Table 2).
Eosinophils appear hierarchically closer to monocytes
than to neutrophils
Figure 1 shows the results of unsupervised clustering
analysis obtained using the condition tree option included
in the GeneSpring package and applying Pearson’s equation
as a correlation measure. Interestingly, the clustering shows
that, despite their commonly described morphological and
physiological characteristics, eosinophils appear hierarchi-
cally closer to monocytes than to neutrophils. Next we
addressed the transcriptome differences between the three
differentiated phenotypes, i.e. monocytes (CD14+), neu-
trophils (CD16+), and eosinophils (CD16–). Using the filter-
ing procedures described in the Design and Methods sec-
tion, we selected a list of 2290 probesets (Supplemental Table
3) showing at least a two-fold difference in one differentiat-
ed phenotype vs all the other cell populations. Moreover,
the gene list of 2209 probesets was uploaded onto MAPP
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Finder 2.0 software to identify prevalent categories in the
GO list of families of biological processes. The GO analy-
sis revealed that the genes preferentially expressed by
eosinophils were mapped in functional categories very
similar to those of genes preferentially expressed by mono-
cytes. In fact, Supplemental Table 4A and C shows that
prevalent categories increased in CD16– and CD14+ cells
were involved in nucleolus metabolism (e.g. nucleolus
organization and biogenesis, nucleologenesis, nucleolus to nucleo-
plasm transport), as well as in DNA repair mechanisms (e.g.
DNA repair, positive regulation of DNA repair, DNA ligation
during DNA repair). Conversely, the prevalent categories
up-regulated in CD16+ were defense response, immune
response, response to biotic stimulus, cell cycle arrest, and nega-
tive regulation of DNA repair (Supplemental Table 4B). In the
light of these results, we next studied the processes of
DNA repair and nucleolar metabolism in detail.
Eosinophils maintain the ability to repair both double-
and single-strand DNA breaks
Genes involved in all DNA repair systems (base excision
repair, nucleotide excision repair, mismatch repair, double-
strand break repair) exhibited, in agreement with their
kinetics and differentiation status,20 a preferential expres-
sion in CD34+ cells with some interesting exceptions. It is,
in fact, worth noting that CD16– and CD14+ cells conserve
the expression of several DNA repair genes, belonging to
all cellular DNA repair systems (Figure 2), while CD16+
cells do not. Next, in order to confirm that the DNA repair
capacity of differentiated myeloid phenotypes differs from
that of CD34+ cells, we tested the cells’ capacity to repair
MMS-induced single-strand DNA breaks21 and mito-
xantrone-induced double-strand DNA breaks,22 using alka-
line and neutral single-cell gel electrophoresis, respectively
(comet assay). As shown in Figure 3, the tail length, inten-
sity and shape differed according to the cell type; in partic-
ular, compared to CD34+ cells, monocytes and eosinophils,
neutrophils showed a higher degree of DNA damage
induced by either mitoxantrone or MMS. Six hours after
removal of the drug CD34+ cells showed a reduction of
approximately 80% in both mitoxantrone- and MMS-
induced DNA damage, whereas CD16– and CD14+ cells
showed a reduction of about 60% in both double- and sin-
gle-strand DNA breaks. Conversely, the comet moment of
neutrophils was only slightly decreased compared with
the same cells at T0 (20% reduction in DNA damage both
the double and single strand comet assays) (Figure 3, pan-
els a-d). 
These data confirm that eosinophils and monocytes
maintain the ability to repair both double and single strand
DNA breaks, whereas neutrophils lack this capacity. 
Eosinophils show a nucleolar activity closer to CD34+
cells than to CD16+ cells 
The global expression analysis of genes involved in RNA
transcription (Figure 2A and Supplemental Figure 2B), splic-
ing, capping and polyadenylation (Supplemental Figure 2C)
showed that the process of RNA maturation is mainly
active in CD34+ cells; as far as concerns myeloid differenti-
ated cells, CD14+ and CD16– cells showed a higher expres-
sion of these genes, as compared with CD16+ cells. 
Moreover, analysis of the expression of genes coding for
ribosomal proteins demonstrated that these transcripts,
which are highly expressed in CD34+, CD16– and CD14+
cells, undergo a remarkable down-regulation in CD16+
cells (Supplemental Figure 3A). Consistently, the same
expression pattern was found for genes coding for nucleo-
lar proteins (Figure 4) and genes involved in protein trans-
lation and modification (Supplemental Figure 3B).  
It has been demonstrated that nucleolar size and the dis-
tribution of main nucleolar components, such as nucleolar
RNA-containing structures and silver-stained nucleolar
organizer regions (AgNOR), correlate with nucleolus activ-
ity.23 Moreover, the differentiation and maturation of blood
cells is accompanied by a decrease in nucleolar size and the
conversion of large nucleoli to ring-shaped nucleoli and
finally to micronucleoli, which reflect the decrease of
nucleolar activities.24 In order to demostate the presence of
different patterns in nucleoli structure and activity, we per-
formed TEM and AgNOR analyses. 
At the ultrastructural level (Figure 5), nucleoli were clear-
ly visible in all cells types (Figure 5A,B,C,D) and frequent-
ly observed in close contact with the chromatin adjacent to
the nuclear membrane. At higher magnification (Figure 5 a,
b, c, d,), both filamentous and the granule nucleolar com-
ponents were recognized in CD34+ (a), CD14+ (b) and
CD16– (c) cells, but not in CD16+ cells (d). Nucleolar segre-
S. Salati et al. 
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Figure 1. Unsupervised clustering analysis. Clustering was per-
formed using an unsupervised approach and applying Pearson’s
correlation equation. A combination of two hierarchical clustering
analyses (gene tree and condition tree) is shown. Gene coloring
was based on normalized signals as shown at the bottom of the
figure.
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gation, which is the separation and migration of the fila-
mentous from the granular component, was frequently
observed in CD16+ cells (Figure 5d). It has been demon-
strated that nucleolar segregation produces a decrease in
the activity of RNA polymerase25 and it is, therefore, con-
ceivable that these changes might be evident in the nucle-
olus when cells have ceased to be active.
Morphometric analysis (Figure 6) showed that the sur-
face area covered by nucleoli  progressively decreased in
CD14+, CD16– and CD16+ cells compared to in CD34+ cells
(Figure 6a); by contrast, the ratio of marginated versus cen-
trally located nucleoli showed the opposite  trend, with
CD16+ cells being the cell type with the highest number of
centrally located nucleoli  (Figure 6b). Our analysis shows
that CD16– cells had numerous nucleoli in close contact
with the chromatin in proximity of the nuclear membrane,
(Figure 5C,c; Figure 6b), similarly to CD14+ cells (Figure 5B,
b; Figure 6b). In contrast, nucleolar margination against the
inner membrane of the nuclear envelope was less evident
in CD16+ cells (Figure 5D, d; Figure 6b). 
The phenomenon of nuclear margination has led many
observers to speculate that such arrangement facilitates
nucleous-cytoplasmic exchanges within the nucleus in
states of active protein synthesis.26
AgNOR analysis showed that, after staining for nucleo-
lar silver-stainable proteins (SSP), nucleoli were detected
only in CD34+ cells, monocytes and eosinophils, whereas
they were undetectable in neutrophils. The nucleoli of
CD34+ cells appeared as clusters of silver-stained particles,
while in monocytes and in eosinophils they appeared
mostly as small single black SSP (Supplemental Figure 4). In
CD34+ cells the number of nucleoli ranged between two to
five, with the mean value of the nucleolar coefficient being
3.25±0.4 (Supplemental Figure 4A). The nucleolar coeffi-
cients decreased to 2.1±0.3 and 1.6±0.2 in monocytes and
eosinophils, respectively, (Supplemental Figures 4B and 4C)
whereas neutrophils did not contain AgNOR-detectable
nucleoli (Supplemental Figure 4D). Monocytes and
eosinophils contained prevalently micronucleoli and, less
frequently, ring-shaped nucleoli, while large nucleoli were
very rare. 
After staining for RNA-containing structures, CD34+ cells
showed large nucleoli with a homogeneous distribution of
RNA, while CD16– and CD14+ cells showed mostly uni-
form staining of micronucleoli. In agreement with the
AgNOR analysis, neutrophils were negative for RNA stain-
ing (data not shown).
Discussion
The two professional phagocytic cell types, neutrophils
and macrophages, develop from a common progenitor cell
called a granulocyte/macrophage progenitor cell.
Molecular and functional characterization of eosinophils
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Figure 2. Expression of genes involved in DNA repair. Eisen tree
map computed using the GeneSpring gene tree and Pearson’s
correlation equation on the modulated probe sets belonging to
the following categories: mismatch repair (MMR, Panel A),
nucleotide excision repair (NER, Panel B), double-strand breaks
repair (DSBR, Panel C), base excision repair (BER, Panel D). The
signal-based coloring legend is shown at the bottom of the figure.
Figure 3. Comet assay. Representative images were taken from
alkaline (Panel A) or neutral (Panel C) comet assays of CD34+,
CD14+, CD16– and CD16+ cells before treatment (UT), immediately
after MMS or mitoxantrone treatment  for 2 hours (T0), and 6 hours
after removal of MMS or mitoxantrone (6h). Panels B and D: Median
relative tail moment of more than 50 cells for each data point, cal-
culated by comparison with the total score (100%) of initial DNA
damage induced by MMS (Panel B) or mitoxantrone (Panel D) treat-
ment. The results reported are representative of five independent
experiments. Mean values±2 SEM (confidence range 95%) were:
MMS (Panel B): CD34+: 19.8±1.71; CD14+: 45.4±2.95; CD16+:
81±6.37 CD16–:39.2±3.3. Mitoxantrone (Panel D): CD34+:
19.8±1.85; CD14+: 45.4±3.42; CD16+: 81±5.37; CD16–:39.2±3.73. 
NE
R
BE
R
M
M
R
DS
BR
MLH1
ABL1
PMS2L1
MSH6
PMS2L9
MSH5
POLE
MSH2
PMS2L11
HTATIP
PRKDC
G22P1
RUVBL2
FANCG
ATR
FEN1
CIB1
NBS1
RAD21
XRCC5
UNG
PARP3
APEX1
MUTYH
MPG
POLG
TDG
HMGB2
PARP2
PARP1
XRCC1
POLB
PARP4
RPA2
XPC
DDB2
ATRX
ERCC1
DDB1
ERCC2
RAD23A
RAD23B
GADD45A
DDX11
ERCC5
PCNA
MMS19L
ERCC3
CENT2
TREX2
CD
14
+
CD
34
+
CD
34
+
CD
16
+
CD
14
+
CD
16
+
CD
16
–
CD
16
–
A
B
D
C
0.1 1 6
A
C D
B
CD34+
CD14+
CD16–
CD16+
UT
-1
0
UT
-T
O
UT
-6
h
UT
-6
h
M
M
S-
T0
M
M
S-
6h
M
ito
xa
nt
ro
ne
TO
M
ito
xa
nt
ro
ne
6h
CD34+
CD14+
CD16–
CD16+
Hours of repair0
0
6
100
90
80
70
60
50
40
30
20
10
0
100
90
80
70
60
50
40
30
20
10
0
6Hours of repair
M
M
S 
da
m
ag
e 
(%
 re
m
ai
ni
ng
)
M
ito
xa
nt
ro
ne
 d
am
ag
e 
(%
 re
m
ai
ni
ng
)
CD34+
CD14+
CD16–
CD16+
CD34+
CD14+
CD16–
CD16+
Neutrophils are highly specialized phagocytic cells that cir-
culate in the blood for only a few hours before migrating
out of capillaries into the connective tissues or other spe-
cific sites, where they survive for only a few days. In con-
trast, circulating monocytes give rise to a variety of tissue-
resident macrophages, as well as to specialized cells such
as dendritic cells and osteoclasts. Monocyte-derived
macrophages can persist for months or perhaps even years
outside the bloodstream, where they can be activated by
local signals to resume proliferation. Due to their highly
restricted specialized functions, short-lived properties and
lack of replication and differentiation ability, neutrophils
are commonly considered terminally differentiated (end-
stage) cells, while monocytes (macrophages) are not,
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Figure 4. Expression of
nucleolar genes. Eisen
tree map computed
using the GeneSpring
gene tree and Pearson’s
correlation equation on
the modulated probe
sets belonging to the
nucleolus category. The
signal-based coloring
legend is shown at the
bottom of the figure.
Figure 5. Transmission electron microscopy of CD34+ (A,a), CD14+
(B,b), CD16– (C,c) and CD16+ (D,d) cells.  Large, marginated nucle-
oli are evident in CD34+, CD14+ and CD16– cells. At higher magni-
fication (a,b,c,d) the ultrastructure of granular and filamentous
components of nucleoli is shown. Nucleolar segregation is fre-
quently observed in CD16+ cells (d). Bar: 1 µm.
Figure 6. Morphometric analysis.  Evaluation of the nucleolar sur-
face (A) and of the ratio of centrally located/marginated nucleoli
(C/M) (B) in CD34+, CD14+, CD16– and CD16+ cells. Significance of
data was assessed by unpaired Student’s t test (A) and by the χ2
test (B).
*p≤0.05, **p≤0.01, ***p≤0.001  vs CD34;
°p≤0.05, °°p≤0.01 vs CD16–
CD34+ CD14+ CD16– CD16+
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because they are multifunctional pleiotropic cells and
maintain some differentiation potential.
Since their discovery, the function of eosinophils has
been disputed. Eosinophils are mainly tissue cells, attract-
ed to mucosal sites by several chemotactic factors. They
express numerous surface receptors, which make them
sensitive to several differentiation, activation and inflam-
matory signals. Despite often being dismissed as short-
lived and relatively limited effector cells regulated by T
cells, eosinophils may give diverse contributions to immu-
nity and homeostasis. In some circumstances tissue dam-
age and disease may be the end result, whereas in others,
eosinophils may be important contributors to the develop-
ment and maintenance of normal tissues.2 Moreover, in
recent years, several authors demonstrated that
eosinophils, unlike neutrophils, are able to survive at least
12 days in inflammed tissues27,28 and there contribute to tis-
sue homeostasis and remodeling. For these reasons,
despite the fact that eosinophils have so far been consid-
ered very similar to neutrophils, it is conceivable that these
complex functions require a more flexible cell machinery
than that of a terminally differentiated cell. 
We, therefore, studied the eosinophil transcriptome pro-
file and compared it with the profiles of neutrophils,
monocytes and CD34+/hematopoietic progenitor cells. 
Unsupervised analysis of the gene expression profiles
showed that the transcriptome profile of eosinophils was
hierarchically closer to monocytes than to neutrophils. We
then focused on the transcriptome differences between
eosinophils, monocytes and neutrophils. 
The analysis of biological processes in which the differ-
entially expressed genes were involved demonstrated that,
compared to neutrophils, eosinophils and monocytes
upregulate genes involved in nucleolus activity and in
DNA repair. These results encouraged us to asses the func-
tionality of the nucleolus and the DNA repair machinery in
eosinophils.  Our data demonstrate that eosinophils main-
tain the ability to repair both double- and single-strand
DNA breaks, while neutrophils lack this capacity. This
supports the concept that eosinophils are not terminally
differentiated cells; in fact, fully efficient DNA repair
machinery is essential for the maintenance of genomic sta-
bility of hematopoietic progenitors and precursors, as well
as mononuclear phagocytes.29,30 Moreover, mismatch repair
deficiency is associated with a hematopoietic repopulation
defect and stem cell exhaustion because of accumulation
of genomic instability.29
In agreement with this concept we also demonstrated
that eosinophils show a nucleolar activity more closely
resembling that of monocytes than that of neutrophils.
Our results confirmed previous data on the presence and
number of nucleoli in hematopoietic progenitors, mono-
cytes and granulocytes18,31 and provided some missing
information on the nucleoli of eosinophils, showing that
these cells contain small nucleoli and some ring-shaped
nucleoli. The presence of ring-shaped nucleoli has been
associated with an immature cell state, which may be
stimulated to further transformation,19 thus supporting
the idea that eosinophils may be capable of additional
maturation. 
Moreover, TEM analysis demonstrated that eosinophils,
when compared to neutrophils, are characterized by a
higher degree of nucleolar margination, which is an indica-
tion of more active protein synthesis.26 Conversely, nucle-
olar segregation, related to a decrease of RNA polymerase
I activity,25 is more evident in neutrophils.
Of particular interest is the finding that nucleophosmin
(NPM1), a nucleolar protein involved in ribosome biogen-
esis and in maintaining genome stability,32 is up-regulated
in CD16– cells as compared to the level in CD16+ cells. 
By regulating p53 in response to DNA-damaging stress,
NPM1 may provide a survival mechanism which allows
the cell to ultimately repair the damage.33 NPM binds both
DNA and RNA, and functions as a histone chaperone dur-
ing the assembly of new nucleosomes and after DNA
lesions have been repaired.34 NPM1 also plays roles in
chromatin remodeling and assembly.35
The presence of large, active nucleoli in eosinophils, cou-
pled with the high activity of these cells’ DNA repair sys-
tems and NPM1 overexpression, may suggest that
cosinophils could undergo further maturation or activa-
tion, as described for monocytes, whereas neutrophils do
not have these properties. In fact, circulating monocytes
give rise to a variety of tissue-resident macrophages
throughout the body, as well as to specialized cells such as
dendritic cells and osteoclasts.36 Blood monocytes continu-
ously repopulate macrophage or dendritic cell populations
to maintain homeostasis and, during inflammation, play
critical roles in innate and adaptive immunity.37
Similarly, it is plausible that eosinophils maintain nucle-
olar and DNA repair functions because they play, as previ-
ously described, important roles in the development and
homeostasis of normal tissues. These functions require
active protein synthesis and DNA repair activities, which
could provide eosinophils with a longer half-life, as already
described for eosinophilic syndromes,38 and the capacity to
affect tissue homeostasis and remodeling. 
Collectively, our results strongly suggest that eosino-
phils, even if considered end-stage granulocytes, are com-
plex multifunctional leukocytes, showing a transcriptome
profile and functional properties closer to those of non-ter-
minally differentiated cells such as monocytes. 
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